ECM boosting peptide: TEGO® Pep 4-17 offers powerful anti-ageing properties
One year after successfully launching its biomimetic TEGO® Pep 4-17, Evonik Goldschmidt GmbH has published further studies to support the peptide’s already noticeable activity.
Earlier in-house trials demonstrated that the skin was perceivably smoother when TEGO® Pep 4-17 was used. Likewise, the study revealed a reduction in skin roughness and strong skin firming activity.
Now further in vivo clinical results, conducted by Prof Krutman from IUF Duesseldorf (Germany), showed a significant increase in the amount of collagen, hyaluronic acid and fibronectin in the dermis. Thus TEGO® Pep 4-17 is able to boost the most important components of the extra-cellular matrix (ECM), which is an important factor for anti-ageing products.
Another facial anti-wrinkle study, done at an independent test institute, verified that this skin-identical peptide improves all kinds of periorbital wrinkles resulting in superior anti-ageing efficacy. This innovative active ingredient is designed for use in anti-ageing preparations as well as anti-wrinkle eye care products.
